Expression of 3 markers and its correlation with prognosis of patients with non-small cell lung cancer
10.3969/j.issn.1673-4130.2017.16.025
- VernacularTitle:3项指标在非小细胞肺癌组织中的表达及其与患者预后的相关性研究
- Author:
Penghua WEI
;
Zhipeng SHEN
;
Hua WANG
;
Suquan QIAN
;
Zhi GAO
- Keywords:
non-small cell lung cancer;
ALCAM;
IL-17RA;
PIK3CA;
expression
- From:
International Journal of Laboratory Medicine
2017;38(16):2243-2245,2248
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expressions of ALCAM,IL-17RA and PIK3CA in patients with non-small cell lung cancer,and to investigate the correlation between the above-mentioned indexes and patients′ prognosis.Methods A total of 65 patients with non-small cell lung cancer admitted to the third People′s Hospital in Liaocheng City were selected and were served as study objects.Immunohistochemical staining(S-P) method was used to detect the expression of ALCAM,IL-17RA and PIK3CA in tissues to analyze the difference of expression between different pathological parameters.And 65 patients were followed up after the operation to compare the survival time of patients in the negative expression group and the positive expression group,and to analyze the correlation between ALCAM,IL-17RA and PIK3CA and the prognosis of the disease.Results Among the 65 cases of patients,47 cases were positive for ALCAM with the positive rate of 72.3%,34 cases were positive for IL-17RA with the positive rate of 52.3%;31 cases were positive for PIK3CA with the positive rate of 47.7%.There was significant difference in the expression of ALCAM,IL-17RA and PIK3CA in patients with different pathological types,TNM staging and lymph node metastasis(P<0.05).There was no significant statistical difference in the expression of patients with different genders and ages(P>0.05).The median survival time of patients with positive results of ALCAM,IL-17RA and PIK3CA were lower than those of negative group,and the differences were statistically significant(P<0.05).Conclusion The expression of ALCAM,IL-17RA and PIK3CA increased in non-small cell lung cancer tissues to remind the higher degree of malignancy and poor prognosis.
